Dendritic cell-tumor cell hybrid vaccination for metastatic cancer. - Wikidata - wikimedia - TriplyDB

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

http://www.wikidata.org/entity/Q34325575

about

Antigen presenting cell/ tumor cell fusion vaccines for cancer immunotherapy Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma Pattern response of dendritic cells in the tumor microenvironment and breast cancer Dendritic cell fusion vaccines for cancer immunotherapy.Trial watch: Dendritic cell-based interventions for cancer therapy Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer.Dendritic cell vaccine strategies for renal cell carcinoma.Recent developments in renal cell cancer immunotherapy.Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.Regulation of tumor immunity by tumor/dendritic cell fusions Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma.What are the molecules involved in regulatory T-cells induction by dendritic cells in cancer?Various ways to improve whole cancer cell vaccines.Cell electrofusion: past and future perspectives for antibody production and cancer cell vaccines.Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets.Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma.High-resolution analyses of cell fusion dynamics in a biochip.Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma.Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures?Cationic liposomes produced via ethanol injection method for dendritic cell therapy.Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy.Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination.Immunotherapy for renal cell carcinoma

P2860

Q26824676-A31A8361-0BDF-429F-99C3-EA19EB0DCDFF Q33726199-E6E641F7-A9AD-48AE-B9DA-E85BCDD581BD Q34023724-C00DB14F-5D45-4684-8BC8-20D0257CF154 Q36150517-33F841B0-BBFC-4F74-A5CF-CDCFB1B5F9C1 Q36388529-857B6A0E-3301-4850-A064-7BC281663A09 Q36485047-48B3379F-6D12-4D70-B4F1-7201F58816E9 Q36717351-DA95DFF3-4692-4648-B889-202A42424BB3 Q36810304-0F6F9A5D-0E5A-4E4D-9198-7FF37CF11964 Q37514725-9F29EB77-055B-4B63-BEA4-544CB7077571 Q37806963-874E34AE-9257-41D7-BF87-676CA31E3CAC Q37838448-7419BBC8-2CEC-4685-AB4C-29FF5A6AF0F0 Q38114070-AE3A8698-417C-4F72-8F09-F4FE629E1B50 Q38206582-AA38A4D7-CA66-4FAC-BC29-58D447E22CFC Q38227953-BDB7F95E-E3F2-4F2A-86D3-4D9EC5FD4AAA Q38342134-D242F4D8-F96C-46E0-818C-57D52C5122BE Q38901871-ABA3B269-C243-4C76-8FBC-C4A7EFCD36E3 Q39296216-1001AD12-7FF7-4E74-AACD-B7E5B4231137 Q40416524-9018147E-7C43-44AF-85AF-C255914C85FE Q43576478-42F15DFF-A8E6-425D-8A1E-8AB20A50A70E Q51261899-41831085-C7FC-4981-B957-D0A5207C449F Q53226038-BCF46873-0071-4B98-8077-CF2BB9A0C5A0 Q53587086-D16D081C-FC2B-403F-A855-A1034364F4A7 Q58652034-C68EC198-E8B4-4550-B374-403D812148F7

P2860

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

http://www.wikidata.org/entity/Q34325575

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@ast

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@en

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@nl

type

label

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@ast

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@en

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@nl

prefLabel

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@ast

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@en

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

@nl

P1433

Q34325575-B8A90C01-885F-437D-A89A-148E85D2B315

P1476

Q34325575-DD11E4B9-838E-4975-B6FE-5B601D3549B3

P2093

Q34325575-4C1A237D-FCFB-4FF6-8C87-1B0E6EF6D1CE

Q34325575-59E40968-53AD-41E3-850D-9B1BDD1A5A91

Q34325575-6B631CD8-92BC-42D5-9029-659648F71864

Q34325575-73B68B12-5299-4798-935A-3FA904FCD01F

Q34325575-767AF568-40CB-4F4A-9812-37490950A47E

Q34325575-959891D4-69CF-497A-94A3-9CE06B169231

Q34325575-C55AFAED-8A08-4B13-88FA-8D8EAC94F068

Q34325575-D12C7BB2-2C26-4B67-B8CF-3CD3A8A691A8

P2888

Q34325575-13E77110-8EAE-4E44-A58A-3EFDFB20681D

P304

Q34325575-2E0E9C0C-E9AA-45B9-887B-BE689E9889BA

P31

Q34325575-343663E3-6919-43BA-897E-97882B8329F7

P356

Q34325575-37FB0BEE-5C36-46A0-9DAC-5971DA5829C2

P433

Q34325575-778E6A7D-37C3-4E2C-A3F9-D5150F8C2433

P478

Q34325575-832FAA17-7A99-4EB9-8DFC-6DBBE54952A9

P50

Q34325575-4A1180ED-13FE-4E42-A51B-A836232DAC21

Q34325575-912141DD-A60B-4D08-AB66-312A659CE938

P577

Q34325575-3EC961E9-F865-44BF-AA81-4CD5373743AC

P6179

Q34325575-B70B33FE-A17E-4BAC-9E25-56CC58BC2263

P698

Q34325575-0A03A130-27B5-45DF-887A-C4EBF4ACFC8A

P356

S00262-004-0551-7

P1433

Cancer Immunology, Immunotherapy

P1476

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer

@en

P2093

Andreia R Neves

http://www.w3.org/2001/XMLSchema#string

Antonio C Buzaid

http://www.w3.org/2001/XMLSchema#string

Frederico Costa

http://www.w3.org/2001/XMLSchema#string

Jose Alexandre M Barbuto

http://www.w3.org/2001/XMLSchema#string

Luiz H Camara-Lopes

http://www.w3.org/2001/XMLSchema#string

Patrícia Bergami-Santos

http://www.w3.org/2001/XMLSchema#string

Ricardo Marques

http://www.w3.org/2001/XMLSchema#string

Siderleny C Martins

http://www.w3.org/2001/XMLSchema#string

P2888

s00262-004-0551-7

P304

1111-1118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-004-0551-7

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Luis F C Ensina

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029144793

http://www.w3.org/2001/XMLSchema#string

P698

15185011

http://www.w3.org/2001/XMLSchema#string